10 20 30 40 50 60 70 80 3CE0 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 27-FEB-08 3CE0
TITLE HUMAN POLY(ADP-RIBOSE) POLYMERASE 3, CATALYTIC FRAGMENT IN TITLE 2 COMPLEX WITH AN INHIBITOR PJ34
COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC FRAGMENT: RESIDUES 178-532; COMPND 5 SYNONYM: PARP-3, NAD(+) ADP-RIBOSYLTRANSFERASE 3, POLY[ADP- COMPND 6 RIBOSE] SYNTHETASE 3, PADPRT-3, HPARP-3, IRT1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP3, ADPRT3, ADPRTL3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4
KEYWDS ENZYME-INHIBITOR COMPLEX, CATALYTIC FRAGMENT, STRUCTURAL KEYWDS 2 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, ALTERNATIVE KEYWDS 3 SPLICING, GLYCOSYLTRANSFERASE, NAD, NUCLEUS, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR L.LEHTIO,T.KARLBERG,C.H.ARROWSMITH,H BERGLUND,C.BOUNTRA, AUTHOR 2 R.BUSAM,R.COLLINS,L.G.DAHLGREN,A.M.EDWARDS,S.FLODIN, AUTHOR 3 A.FLORES,S.GRASLUND,M.HAMMARSTROM,M.D.HERMAN,A.JOHANSSON, AUTHOR 4 I.JOHANSSON,A.KALLAS,T.KOTENYOVA,M.MOCHE,M.E.NILSSON, AUTHOR 5 P.NORDLUND,T.NYMAN,C.PERSSON,J.SAGEMARK,L.SVENSSON, AUTHOR 6 A.G.THORSELL,L.TRESAUGUES,S.VAN DEN BERG,M.WELIN,J.WEIGELT, AUTHOR 7 STRUCTURAL GENOMICS CONSORTIUM (SGC)
REVDAT 3 16-JUN-09 3CE0 1 JRNL REVDAT 2 24-FEB-09 3CE0 1 VERSN REVDAT 1 11-MAR-08 3CE0 0
JRNL AUTH L.LEHTIO,A.S.JEMTH,R.COLLINS,O.LOSEVA,A.JOHANSSON, JRNL AUTH 2 N.MARKOVA,M.HAMMARSTROM,A.FLORES, JRNL AUTH 3 L.HOLMBERG-SCHIAVONE,J.WEIGELT,T.HELLEDAY, JRNL AUTH 4 H.SCHULER,T.KARLBERG JRNL TITL STRUCTURAL BASIS FOR INHIBITOR SPECIFICITY IN HUMAN JRNL TITL 2 POLY(ADP-RIBOSE) POLYMERASE-3. JRNL REF J.MED.CHEM. V. 52 3108 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19354255 JRNL DOI 10.1021/JM900052J
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 8249 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 825 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.3030 - 5.0620 1.00 1270 142 0.1800 0.2520 REMARK 3 2 5.0620 - 4.0300 1.00 1235 137 0.1550 0.2080 REMARK 3 3 4.0300 - 3.5240 1.00 1224 136 0.1880 0.2110 REMARK 3 4 3.5240 - 3.2040 1.00 1247 138 0.2290 0.2910 REMARK 3 5 3.2040 - 2.9750 1.00 1213 135 0.2570 0.3120 REMARK 3 6 2.9750 - 2.8000 1.00 1235 137 0.2870 0.3860 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.41200 REMARK 3 B22 (A**2) : -12.97000 REMARK 3 B33 (A**2) : -4.44300 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : 3.41700 REMARK 3 B23 (A**2) : -0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2813 REMARK 3 ANGLE : 0.490 3814 REMARK 3 CHIRALITY : 0.032 417 REMARK 3 PLANARITY : 0.002 503 REMARK 3 DIHEDRAL : 14.312 1042 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3CE0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-FEB-08. REMARK 100 THE RCSB ID CODE IS RCSB046660.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97627 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8249 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.740 REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.77 REMARK 200 R MERGE FOR SHELL (I) : 0.55100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2PA9 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9 M DL-MALIC ACID, 0.1 M BIS-TRIS REMARK 280 PROPANE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.36000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 176 REMARK 465 MET A 177 REMARK 465 GLY A 242 REMARK 465 PRO A 243 REMARK 465 THR A 244
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 191 CD CE NZ REMARK 470 ASP A 245 CG OD1 OD2 REMARK 470 GLU A 251 CD OE1 OE2 REMARK 470 HIS A 267 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 351 CG CD NE CZ NH1 NH2 REMARK 470 CYS A 352 SG REMARK 470 LYS A 375 CG CD CE NZ REMARK 470 ILE A 427 CG1 CG2 CD1
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 350 -64.71 -100.40 REMARK 500 ASN A 362 68.89 -114.99 REMARK 500 ASN A 378 74.56 52.13 REMARK 500 ALA A 433 -24.71 -160.76 REMARK 500 PRO A 457 3.00 -65.27 REMARK 500 ASP A 478 107.17 -42.77 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P34 A 601
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PA9 RELATED DB: PDB REMARK 900 HUMAN POLY(ADP-RIBOSE) POLYMERASE 3, CATALYTIC FRAGMENT, IN REMARK 900 COMPLEX WITH 3-AMINOBENZOIC ACID REMARK 900 RELATED ID: 3C49 RELATED DB: PDB REMARK 900 HUMAN POLY(ADP-RIBOSE) POLYMERASE 3, CATALYTIC FRAGMENT, IN REMARK 900 COMPLEX WITH KU0058948 REMARK 900 RELATED ID: 3C4H RELATED DB: PDB REMARK 900 HUMAN POLY(ADP-RIBOSE) POLYMERASE 3, CATALYTIC FRAGMENT, IN REMARK 900 COMPLEX WITH AN INHIBITOR DR2313
DBREF 3CE0 A 178 532 UNP Q9Y6F1 PARP3_HUMAN 178 532
SEQADV 3CE0 SER A 176 UNP Q9Y6F1 EXPRESSION TAG SEQADV 3CE0 MET A 177 UNP Q9Y6F1 EXPRESSION TAG
SEQRES 1 A 357 SER MET LYS ARG VAL GLN PRO CYS SER LEU ASP PRO ALA SEQRES 2 A 357 THR GLN LYS LEU ILE THR ASN ILE PHE SER LYS GLU MET SEQRES 3 A 357 PHE LYS ASN THR MET ALA LEU MET ASP LEU ASP VAL LYS SEQRES 4 A 357 LYS MET PRO LEU GLY LYS LEU SER LYS GLN GLN ILE ALA SEQRES 5 A 357 ARG GLY PHE GLU ALA LEU GLU ALA LEU GLU GLU ALA LEU SEQRES 6 A 357 LYS GLY PRO THR ASP GLY GLY GLN SER LEU GLU GLU LEU SEQRES 7 A 357 SER SER HIS PHE TYR THR VAL ILE PRO HIS ASN PHE GLY SEQRES 8 A 357 HIS SER GLN PRO PRO PRO ILE ASN SER PRO GLU LEU LEU SEQRES 9 A 357 GLN ALA LYS LYS ASP MET LEU LEU VAL LEU ALA ASP ILE SEQRES 10 A 357 GLU LEU ALA GLN ALA LEU GLN ALA VAL SER GLU GLN GLU SEQRES 11 A 357 LYS THR VAL GLU GLU VAL PRO HIS PRO LEU ASP ARG ASP SEQRES 12 A 357 TYR GLN LEU LEU LYS CYS GLN LEU GLN LEU LEU ASP SER SEQRES 13 A 357 GLY ALA PRO GLU TYR LYS VAL ILE GLN THR TYR LEU GLU SEQRES 14 A 357 GLN THR GLY SER ASN HIS ARG CYS PRO THR LEU GLN HIS SEQRES 15 A 357 ILE TRP LYS VAL ASN GLN GLU GLY GLU GLU ASP ARG PHE SEQRES 16 A 357 GLN ALA HIS SER LYS LEU GLY ASN ARG LYS LEU LEU TRP SEQRES 17 A 357 HIS GLY THR ASN MET ALA VAL VAL ALA ALA ILE LEU THR SEQRES 18 A 357 SER GLY LEU ARG ILE MET PRO HIS SER GLY GLY ARG VAL SEQRES 19 A 357 GLY LYS GLY ILE TYR PHE ALA SER GLU ASN SER LYS SER SEQRES 20 A 357 ALA GLY TYR VAL ILE GLY MET LYS CYS GLY ALA HIS HIS SEQRES 21 A 357 VAL GLY TYR MET PHE LEU GLY GLU VAL ALA LEU GLY ARG SEQRES 22 A 357 GLU HIS HIS ILE ASN THR ASP ASN PRO SER LEU LYS SER SEQRES 23 A 357 PRO PRO PRO GLY PHE ASP SER VAL ILE ALA ARG GLY HIS SEQRES 24 A 357 THR GLU PRO ASP PRO THR GLN ASP THR GLU LEU GLU LEU SEQRES 25 A 357 ASP GLY GLN GLN VAL VAL VAL PRO GLN GLY GLN PRO VAL SEQRES 26 A 357 PRO CYS PRO GLU PHE SER SER SER THR PHE SER GLN SER SEQRES 27 A 357 GLU TYR LEU ILE TYR GLN GLU SER GLN CYS ARG LEU ARG SEQRES 28 A 357 TYR LEU LEU GLU VAL HIS
HET P34 A 601 22
HETNAM P34 N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6- HETNAM 2 P34 DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
FORMUL 2 P34 C17 H17 N3 O2
HELIX 1 1 ASP A 186 SER A 198 1 13 HELIX 2 2 SER A 198 MET A 209 1 12 HELIX 3 3 PRO A 217 LEU A 221 5 5 HELIX 4 4 SER A 222 ALA A 239 1 18 HELIX 5 5 SER A 249 ILE A 261 1 13 HELIX 6 6 SER A 275 GLN A 299 1 25 HELIX 7 7 SER A 302 THR A 307 1 6 HELIX 8 8 HIS A 313 LEU A 322 1 10 HELIX 9 9 ALA A 333 GLY A 347 1 15 HELIX 10 10 GLU A 366 GLN A 371 1 6 HELIX 11 11 ALA A 372 LEU A 376 5 5 HELIX 12 12 ASN A 387 ALA A 389 5 3 HELIX 13 13 VAL A 390 GLY A 398 1 9 HELIX 14 14 GLU A 418 GLY A 424 1 7 HELIX 15 15 PRO A 479 ASP A 482 5 4 HELIX 16 16 PRO A 503 SER A 506 5 4 HELIX 17 17 GLN A 519 SER A 521 5 3
SHEET 1 A 2 ARG A 179 VAL A 180 0 SHEET 2 A 2 GLU A 310 VAL A 311 1 O VAL A 311 N ARG A 179 SHEET 1 B 5 CYS A 324 LEU A 328 0 SHEET 2 B 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 B 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 B 5 HIS A 434 ALA A 445 -1 N MET A 439 O LEU A 529 SHEET 5 B 5 ARG A 379 THR A 386 -1 N LEU A 382 O GLY A 442 SHEET 1 C 5 CYS A 324 LEU A 328 0 SHEET 2 C 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 C 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 C 5 HIS A 434 ALA A 445 -1 N MET A 439 O LEU A 529 SHEET 5 C 5 MET A 429 CYS A 431 -1 N CYS A 431 O HIS A 434 SHEET 1 D 4 ILE A 413 PHE A 415 0 SHEET 2 D 4 GLU A 514 ILE A 517 -1 O ILE A 517 N ILE A 413 SHEET 3 D 4 SER A 468 ALA A 471 -1 N ALA A 471 O GLU A 514 SHEET 4 D 4 GLU A 449 ILE A 452 1 N HIS A 450 O SER A 468 SHEET 1 E 2 THR A 475 PRO A 477 0 SHEET 2 E 2 PRO A 499 PRO A 501 -1 O VAL A 500 N GLU A 476 SHEET 1 F 2 THR A 483 LEU A 487 0 SHEET 2 F 2 GLN A 490 VAL A 494 -1 O VAL A 494 N THR A 483
SITE 1 AC1 10 ASP A 284 TRP A 383 HIS A 384 GLY A 385 SITE 2 AC1 10 TYR A 414 PHE A 415 LYS A 421 SER A 422 SITE 3 AC1 10 TYR A 425 GLU A 514
CRYST1 56.060 56.720 57.040 90.00 112.51 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017838 0.000000 0.007394 0.00000
SCALE2 0.000000 0.017630 0.000000 0.00000
SCALE3 0.000000 0.000000 0.018978 0.00000